临床开发中的粘膜COVID-19疫苗
Alina Tscherne1, Weina Sun2, Sean T H Liu3
1Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
针对COVID-19的粘膜疫苗提供无针接种,并有可能产生强大的免疫力. 本综述总结了它们的发展,优势以及2019年呼吸道冠状病毒疾病预防的当前临床试验状况.
科学领域:
- 免疫学
- 疫苗学
- 传染性疾病
背景情况:
- 粘膜疫苗通过诱导全身和上呼吸道免疫力对抗COVID-19至关重要.
- 它们提供诸如无针使用和减少病毒传播等优势.
- 临床前和早期临床研究表明,对抗SARS-CoV-2的长期免疫力和保护有希望.
研究的目的:
- 审查粘膜COVID-19疫苗的优缺点.
- 总结粘膜COVID-19疫苗的临床开发情况.
- 突出临床前和临床研究中的高级候选者和关键发现.
主要方法:
- 在动物模型和非人类灵长类动物中进行的临床前研究的审查.
- 对粘膜COVID-19疫苗的早期临床研究的分析.
- 目前已批准/授权和正在研究的粘膜COVID-19疫苗的数据汇编.
主要成果:
- 多种粘膜COVID-19疫苗候选人显示出长期免疫力和保护的潜力.
- 至少有28种粘膜COVID-19疫苗正在临床试验中,另外还有5种已获得批准/许可的疫苗.
- 临床数据的可用性有限,一些试验已经终止或撤回.
结论:
- 粘膜疫苗是预防COVID-19的有希望的下一代疫苗.
- 需要进一步的临床数据来充分评估先进候选药物的疗效和安全性.
- 无针的粘膜疫苗可能会对抗呼吸道病毒疾病的公共卫生策略产生重大影响.
更多相关视频
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
相关概念视频
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Microorganisms in Medicine and Therapeutics
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Preclinical Development: Overview
